BCEIE › News › BAYERCROP

Results

Bayer Cropscience: The Board of Directors at their meeting today , i.e. November 03, 2026, has inter alia approved

Bayer Cropscience (BAYERCROP) filed a disclosure titled "The Board of Directors at their meeting today , i.e. November 03, 2026, has inter alia approved". The company is valued at about ₹14,738 crore.

BCEIE News Desk · Published 3 Nov 2026, 07:05 pm IST · Filing received 3 Nov 2026, 06:50 pm IST

What happened

Bayer Cropscience (BAYERCROP) filed a disclosure with the exchanges on 3 November 2026 at 06:50 PM titled "The Board of Directors at their meeting today , i.e. November 03, 2026, has inter alia approved".

Company snapshot

Bayer Cropscience is a small-cap company in the Chemicals sector, with a market value of about ₹14,738 crore.

The stock last traded at ₹3,279.4, against a 52-week range of ₹3,240–₹5,063 (35.2% below the high).

Before this filing the shares had moved −9.6% over the month and −23.8% over three months. Average daily turnover over the last 20 sessions was about ₹9.79 crore.

Promoters held 71.43% at the end of Q1 FY27. Foreign institutions owned 3.97% and domestic institutions 11.64%.

Quarterly results (standalone, ₹ crore)
QuarterRevenueNet profitEPS (₹)
Q1 FY261,915278.762.01
Q2 FY261,553152.733.98
Q3 FY261,10695.721.29
Q4 FY261,101162.136.07
Q1 FY271,835321.671.56

What history shows

This is not the company's first results disclosure: BCEIE has 1 earlier filing of this kind on record since May 2026.

Across 221 similar disclosures by other Chemicals companies, shares moved −1.3% on average the next day and −1.1% over five days; 37% of them rose the next day.

Market-wide, 10,321 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

  • Management commentary, margins and order book or guidance in the investor presentation.

In the news

Recent coverage elsewhere (links open the original publisher):

Source

Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.

More on Bayer Cropscience Limited